161 related articles for article (PubMed ID: 33153468)
41. Brief Report: Viral Load Monitoring in Pregnancy to Predict Peripartum Viremia in South Africa.
Odayar J; Kabanda S; Malaba TR; Lesosky M; Myer L
J Acquir Immune Defic Syndr; 2021 Sep; 88(1):6-9. PubMed ID: 34050102
[TBL] [Abstract][Full Text] [Related]
42. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
Onoya D; Sineke T; Brennan AT; Long L; Fox MP
AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
[TBL] [Abstract][Full Text] [Related]
43. Cohort profile: CareConekta: a pilot study of a smartphone application to improve engagement in postpartum HIV care in South Africa.
Clouse K; Noholoza S; Ngcobo N; Madwayi S; Mrubata M; Camlin CS; Myer L; Phillips TK
BMJ Open; 2022 Nov; 12(11):e064946. PubMed ID: 36414286
[TBL] [Abstract][Full Text] [Related]
44. Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.
Osler M; Cornell M; Ford N; Hilderbrand K; Goemaere E; Boulle A
J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25530. PubMed ID: 32589367
[TBL] [Abstract][Full Text] [Related]
45. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
[TBL] [Abstract][Full Text] [Related]
46. Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa.
Adeniyi OV; Selanto-Chairman N; Owolabi EO; Ajayi AI; Kayembe DK; Ter Goon D; Gordana A; Lambert J
BMC Public Health; 2019 Oct; 19(1):1407. PubMed ID: 31664978
[TBL] [Abstract][Full Text] [Related]
47. Syphilis screening coverage and positivity by HIV treatment status among South African pregnant women enrolled in the 2019 antenatal HIV sentinel survey.
Kufa T; Woldesenbet S; Cheyip M; Ayalew K; Kularatne R; Manda S; Lombard C; Puren A
Sci Rep; 2023 Apr; 13(1):5322. PubMed ID: 37005466
[TBL] [Abstract][Full Text] [Related]
48. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
[TBL] [Abstract][Full Text] [Related]
49. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
50. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis.
Schnippel K; Mongwenyana C; Long LC; Larson BA
BMC Infect Dis; 2015 Feb; 15():46. PubMed ID: 25656597
[TBL] [Abstract][Full Text] [Related]
51. Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.
Price AJ; Kayange M; Zaba B; Chimbwandira FM; Jahn A; Chirwa Z; Dasgupta AN; Katundu C; Saul JL; Glynn JR; Koole O; Crampin AC
Sex Transm Infect; 2014 Jun; 90(4):309-14. PubMed ID: 24714445
[TBL] [Abstract][Full Text] [Related]
52. Approaches to transitioning women into and out of prevention of mother-to-child transmission of HIV services for continued ART: a systematic review.
Phillips TK; Teasdale CA; Geller A; Ng'eno B; Mogoba P; Modi S; Abrams EJ
J Int AIDS Soc; 2021 Jan; 24(1):e25633. PubMed ID: 33372730
[TBL] [Abstract][Full Text] [Related]
53. Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa.
Woldesenbet SA; Kufa T; Barron P; Chirombo BC; Cheyip M; Ayalew K; Lombard C; Manda S; Diallo K; Pillay Y; Puren AJ
AIDS; 2020 Mar; 34(4):589-597. PubMed ID: 31821189
[TBL] [Abstract][Full Text] [Related]
54. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
[TBL] [Abstract][Full Text] [Related]
55. Long-Term Outcomes of HIV-Infected Women Receiving Antiretroviral Therapy After Transferring Out of an Integrated Maternal and Child Health Service in South Africa.
Phillips TK; Mogoba P; Brittain K; Gomba Y; Zerbe A; Myer L; Abrams EJ
J Acquir Immune Defic Syndr; 2020 Mar; 83(3):202-209. PubMed ID: 31725060
[TBL] [Abstract][Full Text] [Related]
56. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa.
Clouse K; Pettifor A; Shearer K; Maskew M; Bassett J; Larson B; Van Rie A; Sanne I; Fox MP
Trop Med Int Health; 2013 Apr; 18(4):451-60. PubMed ID: 23374278
[TBL] [Abstract][Full Text] [Related]
57. Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania.
Watt MH; Cichowitz C; Kisigo G; Minja L; Knettel BA; Knippler ET; Ngocho J; Manavalan P; Mmbaga BT
AIDS Care; 2019 Jun; 31(6):687-698. PubMed ID: 30466304
[TBL] [Abstract][Full Text] [Related]
58. Awareness of HIV-positive status and linkage to treatment prior to pregnancy in the "test and treat" era: A national antenatal sentinel survey, 2017, South Africa.
Woldesenbet S; Kufa T; Cheyip M; Ayalew K; Lombard C; Manda S; Nadol P; Barron P; Chirombo B; Igumbor E; Pillay Y; Puren A
PLoS One; 2020; 15(3):e0229874. PubMed ID: 32168356
[TBL] [Abstract][Full Text] [Related]
59. Prevention-of-mother-to-child-transmission (PMTCT) program outcomes in South Africa in the pre-COVID and COVID eras.
Naidoo K; Hoque M; Buckus S; Hoque M; Jagernath K
BMC Public Health; 2023 Jul; 23(1):1395. PubMed ID: 37474920
[TBL] [Abstract][Full Text] [Related]
60. Development and validation of a novel scale for antiretroviral therapy readiness among pregnant women in urban Zambia with newly diagnosed HIV infection.
Mubiana-Mbewe M; Bosomprah S; Saroj RK; Kadota J; Koyuncu A; Thankian K; Vinikoor MJ
AIDS Res Ther; 2023 Apr; 20(1):21. PubMed ID: 37024961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
